Colorado

Five-Year Summary: July 2005 to June 2010

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2011 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Program Overview

Women Served through the NBCCEDP

Category	Number
Women served [1]	45,646
Women screened [2]	45,592
Women receiving Pap tests	32,864
Women receiving mammography	25,874

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

2: Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data source: April 2011 submission of NBCCEDP Minimum Data Elements (MDE).

Cervical Cancer Screening

Distribution of Women Receiving Pap Tests by Race/Ethnicity

This pie chart illustrates the distribution of 32,864 women receiving an NBCCEDP-funded Pap test from July 2005 to June 2010 by race and ethnicity.

Distribution of Women Receiving Pap Tests by Age

This pie chart illustrates the distribution of 32,864 women receiving an NBCCEDP-funded Pap test from July 2005 to June 2010 by age.

* Slices too small to view were combined into the Other Ages slice (0.6%) and include: 30 to 39 (<0.1%) and 65 and older (0.5%).   Differences are due to rounding.

Cervical Results and Outcomes

Category	Number
Pap tests provided	45,897
Pap tests with abnormal results [1]	966
Percentage of Pap with abnormal results	2.1
Age-adjusted percentage [2]	1.7
Cervical cancers or premalignant cervical lesions [3]	652
CIN-1 or LSIL	413
CIN-2 or worse [4]	239
Rate of CIN-2 or worse detected per 1,000 Pap tests [4]	5.2
Age-adjusted rate per 1,000 Pap tests [2]	4.3

1: Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance - cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

2: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

3: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)-1, CIN-2, CIN-3, carcinoma in situ (CIS), and invasive cervical cancer.

4: Includes HSIL, CIN-2, CIN-3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests. Additionally, less than 16 women, not included above, were diagnosed with LSIL, HSIL, CIN-1, CIN-2, CIN-3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source.

Breast Cancer Screening

Distribution of Women Receiving Mammograms by Race/Ethnicity

This pie chart illustrates the distribution of 25,874 women receiving an NBCCEDP-funded mammogram from July 2005 to June 2010 by race and ethnicity.

Distribution of Women Receiving Mammograms by Age

This pie chart illustrates the distribution of 25,874 women receiving an NBCCEDP-funded mammogram from July 2005 to June 2010 by age.

Breast Results and Outcomes

Category	Number
Mammograms provided	38,705
Mammograms with abnormal results [1]	7,214
Percentage of mammograms with abnormal results	18.6
Age-adjusted percentage [2]	18.9
Breast cancers detected [3]	526
Rate of breast cancers detected per 1,000 mammograms	13.6
Age-adjusted rate per 1,000 mammograms [2]	13.9

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 65 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.